🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

9550+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 9550 recruiting trials

Phase 3RecruitingNCT07446894

MSA-01 in Multiple System Atrophy

🏥 Tokyo University📍 12 sites📅 Started Feb 2026View details ↗
Phase 3RecruitingNCT07220772

A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT06016634

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

👨‍⚕️ Oyebimpe O Adesina, MD, MS, UC Davis School of Medicine📍 1 site📅 Started Feb 2026View details ↗
RecruitingNCT07127926

Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD

👨‍⚕️ Amin Alousi, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Feb 2026View details ↗
NAEnrolling by InvitationNCT07298486

Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALS

👨‍⚕️ Kayla Chomko, PT, DPT, Nova Southeastern University📍 1 site📅 Started Feb 2026View details ↗
Phase 1RecruitingNCT06859008

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

👨‍⚕️ Geoffrey Shouse, City of Hope Medical Center📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07410520

PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.

🏥 The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07489209

A Dose-exploration Study of EDP167 in HoFH

👨‍⚕️ Kefei Dou, MD, Chinese Academy of Medical Sciences, Fuwai Hospital📍 1 site📅 Started Feb 2026View details ↗
RecruitingNCT07388966

Prospective Longitudinal Monocentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia

👨‍⚕️ Genevieve Baujat, Hopital Necker📍 1 site📅 Started Feb 2026View details ↗
NARecruitingNCT07359911

Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patients

👨‍⚕️ Tracy E Crane, PhD, RDN, University of Miami📍 1 site📅 Started Feb 2026View details ↗
RecruitingNCT07438691

Outcomes in ARMs: Comparison Between Surgical Techniques in Patients With Perineal or Vestibular Fistula - a Multicenter Italian Study

👨‍⚕️ Riccardo Coletta, Meyer IRCSS📍 21 sites📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07304089

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

🏥 Vima Therapeutics📍 36 sites📅 Started Feb 2026View details ↗
Phase 1, PHASE2RecruitingNCT07250750

A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

🏥 ImmunAbs Inc.📍 25 sites📅 Started Feb 2026View details ↗
NARecruitingNCT07251933

A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries

👨‍⚕️ Study Director, Takeda📍 20 sites📅 Started Feb 2026View details ↗
NARecruitingNCT07222475

Writing Relaxing Beats in Adolescents Who Have Sickle Cell Disease

👨‍⚕️ C. Robert Bennett, PhD, Mayo Clinic📍 1 site📅 Started Feb 2026View details ↗
Phase 3RecruitingNCT07377578

A Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With Relapsed or Refractory Mantle Cell Lymphoma

🏥 Guangzhou Lupeng Pharmaceutical Company LTD.📍 2 sites📅 Started Feb 2026View details ↗
RecruitingNCT06447064

Cancer Loyalty Card Study 2 (CLOCS-2)

👨‍⚕️ Dr James Flanagan, Imperial College London📍 1 site📅 Started Feb 2026View details ↗
Phase 1, PHASE2RecruitingNCT07480954

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)

🏥 Beijing Biotech📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07399704

A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease

🏥 Azafaros A.G.📍 3 sites📅 Started Feb 2026View details ↗
NARecruitingNCT07447011

Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea

👨‍⚕️ Ali MA Ismail, lecturer, Cairo University📍 1 site📅 Started Feb 2026View details ↗
← PreviousPage 14 of 478Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →